Mike Allan Mortensen

Mike Allan Mortensen is a clinical researcher in the Department of Clinical Research at the University of Southern Denmark, affiliated with the Research Unit of Urology in Odense. His work focuses on urological oncology, particularly prostate cancer diagnosis, treatment, and surgical innovation. He contributes to clinical research involving robotic surgery, PET/CT imaging, and biomarker validation.

His research interests lie at the intersection of urology, oncology, and surgical technology. He investigates prostate cancer detection using urine and plasma biomarkers, AI-driven analysis of PET/CT scans for lymph node metastasis, and performance assessment in robot-assisted radical prostatectomy. His studies often involve prospective clinical designs and collaborations across Danish medical centers.

The recent publications indicate a strong trend toward integrating artificial intelligence in diagnostic imaging, enhancing surgical evaluation methods, and improving risk stratification in prostate cancer. His work bridges clinical practice with technological innovation in urological oncology.

Scientific Awards:

• No scientific awards mentioned in the provided text.

Advising and Grants:

• No formal students or advisees listed.
• No grants explicitly mentioned, though involvement in prospective studies suggests potential grant-supported research.

Labs and Teams:
Dr. Mortensen is part of the Research Unit of Urology at Odense University Hospital and collaborates within the clinical research network at the University of Southern Denmark. His work involves multidisciplinary teams in urology, radiology, and medical technology, particularly in AI applications and surgical simulation research.